RTTNews | Jan 10, 2022 08:31AM EST

08:31 Monday, January 10, 2022 (RTTNews) - Halozyme Therapeutics Expects 2022 EPS Of $1.90 To $2.05 And 2022 Non-GAAP EPS Of $2.05 To $2.20

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2022 RTTNews.com. All Rights Reserved